FDA proscribes Chinese toothpaste

The FDA follows its proud tradtion of Friday afternoon recalls!

The issue is the adulteration/replacement of glycerin with diethylene glycol, which tastes similar, but is very poisonous. This story has been well covered in the last few weeks.

My question is, why only toothpaste? I would have extended the ban on all products containing glycerin. But, the FDA is a cautious beast, so things happen slowly and incrementally, if at all.

FDA News Release

The U.S. Food and Drug Administration (FDA) today warned consumers to avoid using tubes of toothpaste labeled as made in China, and issued an import alert to prevent toothpaste containing the poisonous chemical diethylene glycol (DEG) from entering the United States.

DEG is used in antifreeze and as a solvent.

Consumers should examine toothpaste products for labeling that says the product is made in China. Out of an abundance of caution, FDA suggests that consumers throw away toothpaste with that labeling. FDA is concerned that these products may contain “diethylene glycol,” also known as “diglycol” or “diglycol stearate.”

FDA is not aware of any U.S. reports of poisonings from toothpaste containing DEG. However, the agency is concerned about potential risks from chronic exposure to DEG and exposure to DEG in certain populations, such as children and individuals with kidney or liver disease. DEG in toothpaste has a low but meaningful risk of toxicity and injury to these populations. Toothpaste is not intended to be swallowed, but FDA is concerned about unintentional swallowing or ingestion of toothpaste containing DEG.

FDA has identified the following brands of toothpaste from China that contain DEG and are included in the import alert: Cooldent Fluoride; Cooldent Spearmint; Cooldent ICE; Dr. Cool, Everfresh Toothpaste; Superdent Toothpaste; Clean Rite Toothpaste; Oralmax Extreme; Oral Bright Fresh Spearmint Flavor; Bright Max Peppermint Flavor; and ShiR Fresh Mint Fluoride Paste. Manufacturers of these products are: Goldcredit International Enterprises Limited; Goldcredit International Trading Company Limited; and Suzhou City Jinmao Daily Chemicals Company Limited. The products typically are sold at low-cost, “bargain” retail outlets.

Based on reports of contaminated toothpaste from China found in several countries, including Panama, FDA increased its scrutiny and began sampling toothpaste and other dental products manufactured in China that were imported into the United States.

FDA inspectors identified and detained one shipment of toothpaste at the U.S. border, containing about 3 percent DEG by weight. In addition, FDA inspectors found and tested toothpaste products from China located at a distribution center and a retail store. The highest level found was between 3-4 percent by weight. The product at the retail store was not labeled as containing DEG but was found to contain the substance.

DEG poisoning is an important public safety issue. The agency is aware of reports of patient deaths and injuries in other countries over the past several years from ingesting DEG-contaminated pharmaceutical preparations, such as cough syrups and acetaminophen syrup. FDA recently issued a guidance document to urge U.S. pharmaceutical manufacturers to be vigilant in assuring that glycerin, a sweetener commonly used worldwide in liquid over-the-counter and prescription drug products, is not contaminated with DEG.

FDA continues to investigate this problem. If FDA identifies other brands of toothpaste products containing DEG, FDA will take appropriate actions, including adding products and their manufacturers to the import alert to prevent them from entering the United States.

Similar Posts

  • Melamine movin' on up the food chain

    The FDA mentioned recently that the melamine suspected of poisoning many cats had gotten into pig feed in California, well, it gets worse…

    Tuesday: Uh-Oh — North Carolina Public Radio WUNC

    The FDA announced this afternoon that thousands of hogs in NC and four or five other states are now under quarantine because they were fed tainted rice gluten. Hogs here and in CA have tested positive for melamine. No one knows yet whether it poses any dangers to humans who ate the hogs, but the feds say they’re trying to find out.

    At this point in time, I would consider any animal feed from China suspect. Way out of control, because we have no procedure for being proactive about these things…

    It won’t amount to much because melamine apparently does not affect humans as much as it seems to affect cats, but it is the utter lack of control of ingredients and raw materials that scares me. What else can sneak through? What if the next one is actually deadly to humans?

  • Industry Funding may Bias Nutritional Health Research

    Not a truly surprising finding, given the enormous profits at stake for the Nestle’s of the world.

    PLoS Medicine – Relationship between Funding Source and Conclusion among Nutrition-Related Scientific Articles

    Funding source was significantly related to conclusions when considering all article types (p = 0.037). For interventional studies, the proportion with unfavorable conclusions was 0% for all industry funding versus 37% for no industry funding (p = 0.009). The odds ratio of a favorable versus unfavorable conclusion was 7.61 (95% confidence interval 1.27 to 45.73), comparing articles with all industry funding to no industry funding. Conclusions: Industry funding of nutrition-related scientific articles may bias conclusions in favor of sponsors’ products, with potentially significant implications for public health.

    Note the zero, as in, the number of unfavorable conclusions in wholly industry funded interventional studies.

    interventional study—if humans consumed, or if human tissue was exposed to, a food or food component with the intention of measuring a biological response

    Well, not surprising. You can exert much tighter control on an interventional study where you control most of the variables. Seems like there’s some predestination going on here!

    What do the authors think is going on here?

    (1) Industrial sponsors may fund only those studies that they believe will present their products in a favorable light, or their competitors’ products in an unfavorable light. In support of this possibility, all studies funded entirely by industry were characterized as “benefit” or “antagonism” with regard to the product under study (none were characterized as “no relationship”). That is, industrial organizations do not seem to sponsor articles about products in which they have no financial interest. (2) Investigators might formulate hypotheses, design studies, or analyze data in ways that are consistent with the financial interests of their industrial sponsors. (3) Industrial sponsors or investigators may choose to delay or not publish findings that have negative implications to the sponsor’s product. (4) Authors of scientific reviews may search and interpret the literature selectively, in ways consistent with the sponsor’s interests. (5) Scientific reviews arising from industry-supported scientific symposia, often published as journal supplements, may over- or under-represent certain viewpoints, if presenters whose opinions conflict with the sponsor’s financial interests are not invited to participate.

    All good points. Remember next time you read an article in the paper about how exercise is much more important in determining obesity compared to your average sugary drink. Remember that a 12 Oz can of coke contains 39 grams of sugar, or 8 teaspoons worth!

  • |

    Asbestos stays off global dangerous-substance list

    NDP MP Pat Martin said Tuesday the Canadian delegation did not even participate in the discussions this year but got others to work on their behalf instead.

    He accused the Canadians of browbeating developing nations such as India, Pakistan and Vietnam — some of Canada's largest chrysotile customers — into opposing its inclusion on the list.

    "It's not a proud day for our country," said Martin, who attended the convention and spoke by telephone from Rome.

    via Chrysotile asbestos stays off global dangerous-substance list

    Canadians can now breathe easy. The government did not even have to oppose a notification officially, other countries did it for them.

  • |

    India drastically reduces AIDs incidence

    India’s efforts at combating AIDs through the use of superior statistics and survey techniques (yes, we are geeky like that only!) pays off as the number of AIDs cases is slashed from 5.7 million to close to 3 million.

    Study: Fewer Indians with HIV seen – Yahoo News

    The number of Indians infected with HIV is far smaller than previously believed, according to new data that appears to vindicate critics who said earlier U.N. assessments of the country’s epidemic were vastly overestimated.

    Experts say the still-unreleased survey is likely to show that India’s number of HIV cases, which last year was said to be the highest in the world at 5.7 million, is actually well below that mark.

    “The actual number we’ve come up with in aggregate is likely to be lower, and perhaps substantially lower,” said Ashok Alexander, director of the Avahan, the Indian program of the Bill & Melinda Gates Foundation, which helped fund the study.

    Now, if we can only make the other 3 million cases go away. Unfortunately, math is not going to get us there. But this is good news, I guess, for the 2.7 million people who we thought had AIDs, but actually did not. Were these poor people clued in?

    The real reason this is good news is that if money was budgeted to take care of 5.7 million cases, then it will go a little further now! Happy Friday, takes away from all the other crap going on in my world that I am too jaded and cynical to blog about.

  • | |

    Colonialism, Pharmaceutical style

    Legal wrangle puts India’s generic drugs at risk – health – 29 January 2007 – New Scientist

    Tens of thousands of people being treated for AIDS will suffer if Swiss pharmaceutical company Novartis succeeds in changing India’s patent law, the humanitarian agency Medecins Sans Frontieres warned on Monday. Novartis is challenging a specific provision of India’s patent law that, if overturned, would see patents being granted far more widely, heavily restricting the availability of affordable generic medicines, MSF says.

    In 2000, antiretroviral (ARV) treatment cost was estimated at $10,000 per patient annually. But the availability of generic drugs produced mainly in India, allowed costs to plummet to about $70 per patient per year, Mwangi adds.

    You’ve got to love the friendly multinational arguing to make extra billions while people die. But I don’t think any Indian judge will overthrow Indian patent law. And there is a national interest  exemption built into most patent statutes, per the TRIPs agreements.

  • |

    Chip Implants Linked to Animal Tumors

    Thinking about implanting an RFID microchip under your skin? Don’t do it! Why would the FDA approve something that was linked to cancers in rats?

    Chip Implants Linked to Animal Tumors – washingtonpost.com:

    When the U.S. Food and Drug Administration approved implanting microchips in humans, the manufacturer said it would save lives, letting doctors scan the tiny transponders to access patients’ medical records almost instantly. The FDA found ‘reasonable assurance’ the device was safe, and a sub-agency even called it one of 2005’s top ‘innovative technologies.’

    But neither the company nor the regulators publicly mentioned this: A series of veterinary and toxicology studies, dating to the mid-1990s, stated that chip implants had ‘induced’ malignant tumors in some lab mice and rats.

    ‘The transponders were the cause of the tumors,’ said Keith Johnson, a retired toxicologic pathologist, explaining in a phone interview the findings of a 1996 study he led at the Dow Chemical Co. in Midland, Mich.

    Leading cancer specialists reviewed the research for The Associated Press and, while cautioning that animal test results do not necessarily apply to humans, said the findings troubled them. Some said they would not allow family members to receive implants, and all urged further research before the glass-encased transponders are widely implanted in people.

    To date, about 2,000 of the so-called radio frequency identification, or RFID, devices have been implanted in humans worldwide, according to VeriChip Corp. The company, which sees a target market of 45 million Americans for its medical monitoring chips, insists the devices are safe, as does its parent company, Applied Digital Solutions, of Delray Beach, Fla.